CA1203173A - Fat emulsion containing prostaglandin e.sub.1 and method for production thereof - Google Patents

Fat emulsion containing prostaglandin e.sub.1 and method for production thereof

Info

Publication number
CA1203173A
CA1203173A CA000430549A CA430549A CA1203173A CA 1203173 A CA1203173 A CA 1203173A CA 000430549 A CA000430549 A CA 000430549A CA 430549 A CA430549 A CA 430549A CA 1203173 A CA1203173 A CA 1203173A
Authority
CA
Canada
Prior art keywords
weight
fat emulsion
emulsion
pgel
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000430549A
Other languages
English (en)
French (fr)
Inventor
Tadakazu Suyama
Kazumasa Yokoyama
Susumu Otomo
Hironaka Aihara
Yutaka Mizushima
Hiroyuki Okamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Taisho Pharmaceutical Co Ltd
Original Assignee
Green Cross Corp Japan
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14390874&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1203173(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp Japan, Taisho Pharmaceutical Co Ltd filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of CA1203173A publication Critical patent/CA1203173A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000430549A 1982-06-18 1983-06-16 Fat emulsion containing prostaglandin e.sub.1 and method for production thereof Expired CA1203173A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP104814/82 1982-06-18
JP57104814A JPS58222014A (ja) 1982-06-18 1982-06-18 プロスタグランジンｅ↓１脂肪乳剤

Publications (1)

Publication Number Publication Date
CA1203173A true CA1203173A (en) 1986-04-15

Family

ID=14390874

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000430549A Expired CA1203173A (en) 1982-06-18 1983-06-16 Fat emulsion containing prostaglandin e.sub.1 and method for production thereof

Country Status (8)

Country Link
US (1) US4493847A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0097481B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS58222014A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880001756B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE22657T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1203173A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3366662D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA834458B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
JPS6253922A (ja) * 1985-09-02 1987-03-09 Tetsuzo Sugizaki 腎炎予防・治療剤
JPS63246330A (ja) * 1987-03-31 1988-10-13 Isamu Koyama 腎臓温阻血障害改善剤
WO1988009170A1 (en) * 1987-05-22 1988-12-01 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5811118A (en) * 1987-05-22 1998-09-22 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
JP2600726B2 (ja) * 1987-11-30 1997-04-16 大正製薬株式会社 微粒子脂肪乳剤
JP2926749B2 (ja) 1989-04-25 1999-07-28 吉富製薬株式会社 プロスタグランジン含有液状組成物
JPH0669966B2 (ja) * 1989-07-05 1994-09-07 株式会社ミドリ十字 血管造影補助剤
JPH03101622A (ja) * 1989-09-11 1991-04-26 Green Cross Corp:The 肝炎予防治療剤
US5194670A (en) * 1989-10-16 1993-03-16 Yutaka Mizushima, Asahi Glass Company Ltd. Emulsion of lipid containing a prostaglandin analogue
JP2602964B2 (ja) * 1989-10-16 1997-04-23 裕 水島 プロスタグランジン類縁体およびその脂肪乳剤
JP2653245B2 (ja) * 1989-11-27 1997-09-17 日本新薬株式会社 脂肪乳剤
US4966779A (en) * 1989-12-21 1990-10-30 Basf Corporation Stable, water miscible emulsion comprising a fat-soluble vitamin
US5882678A (en) * 1990-01-12 1999-03-16 The Liposome Co, Inc. Interdigitation-fusion liposomes containing arachidonic acid metabolites
EP0512916B1 (en) * 1991-05-07 1999-02-03 The Liposome Company, Inc. Liposomal prostaglandin formulations
DE69418255T2 (de) * 1993-02-03 1999-12-02 Yutaka Mizushima Pharmazeutische zusammensetzung zur behandlung der zerebralthrombose
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
SE9303281D0 (sv) * 1993-10-07 1993-10-07 Astra Ab New formulation
US5840328A (en) * 1994-01-11 1998-11-24 The Liposome Company, Inc. Treatment using arachidonic acid metabolite and particulate formulations
WO1997009986A1 (fr) * 1995-09-13 1997-03-20 Nippon Shinyaku Co., Ltd. Preparation lyophilisee contenant de la pge1 et son procede de production
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
DE19607296A1 (de) * 1996-02-27 1997-08-28 Kodak Ag Heftvorrichtung zum Zusammenheften von Blättern
DE19645657A1 (de) * 1996-11-06 1998-05-28 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung, Verfahren zur Herstellung einer derartigen Zusammensetzung und Verwendung derselben
US6288113B1 (en) 1997-08-27 2001-09-11 Welfide Corporation Angiogenesis promoters
EP1467259B1 (en) * 2003-04-07 2009-02-18 Canon Kabushiki Kaisha Magnetic toner
ATE549014T1 (de) 2006-09-05 2012-03-15 Q P Corp Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel
ES2466865T3 (es) 2010-05-21 2014-06-11 Nestec S.A. Dispositivo de distribución de vapor o agua caliente que se puede almacenar
CN103536532A (zh) * 2013-10-25 2014-01-29 北京蓝丹医药科技有限公司 一种前列地尔组合物及其制备方法
EP3589175B1 (en) 2017-02-28 2023-08-23 Société des Produits Nestlé S.A. Dispenser with parallel dispensing paths
CN107137351B (zh) * 2017-06-05 2020-08-04 辅必成（上海）医药科技有限公司 一种稳定的前列地尔乳剂注射液

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT196914163A (es) * 1968-08-29 1971-01-26 Composicion y proceso
US4016290A (en) * 1973-11-12 1977-04-05 The United States Of America As Represented By The United States Energy Research And Development Administration Method of encapsulating polyaminopolycarboxylic acid chelating agents in liposomes
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
US4302459A (en) * 1980-03-19 1981-11-24 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤

Also Published As

Publication number Publication date
JPH0157094B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-12-04
DE3366662D1 (en) 1986-11-13
EP0097481B1 (en) 1986-10-08
ZA834458B (en) 1984-03-28
JPS58222014A (ja) 1983-12-23
KR840005019A (ko) 1984-11-03
KR880001756B1 (ko) 1988-09-12
ATE22657T1 (de) 1986-10-15
EP0097481A1 (en) 1984-01-04
US4493847A (en) 1985-01-15

Similar Documents

Publication Publication Date Title
CA1203173A (en) Fat emulsion containing prostaglandin e.sub.1 and method for production thereof
US4849451A (en) Fat emulsion containing prostaglandin
EP0231091B1 (en) Stable emulsions of highly fluorinated organic compound
JPS609726B2 (ja) ステロイド製剤
HU199282B (en) Process for producing parenteral pharmaceutical emulsion compositions containing hardly water soluble active components of basic caracter
JPH0818989B2 (ja) 脂肪乳剤中のプロスタグランジンの安定化方法
US5445812A (en) Angiographic adjuvant
EP0418004B1 (en) Preventive and therapeutic agent for hepatitis
JPH0566929B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0128727B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0357087B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA2302023A1 (en) Angiogenesis promoter
EP0659072B1 (en) Pharmaceutical emulsions containing bioactive steroids
JP2851704B2 (ja) 脳血栓症治療のための薬学的組成物
JPH0461854B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2722416B2 (ja) 脳腫瘍内移行改善剤
JPS59130812A (ja) 癌化学療法補助剤
JPH0769897A (ja) 血中トリグリセリド低下作用剤
JPH0513926B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0157095B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0489430A (ja) 低血圧維持剤
JPH1160491A (ja) アムホテリシンｂ含有製剤
JPH04342530A (ja) ７−フルオロプロスタサイクリン類脂肪乳剤
JPH051245B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH05279258A (ja) 免疫抑制剤

Legal Events

Date Code Title Description
MKEX Expiry